Voloridge Investment Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Sell
45,625
-59,687
-57% -$15.8M 0.09% 284
2026
Q1
$11.5M Buy
105,312
+6,157
+6% +$877K 0.05% 469
2025
Q4
$16.5M Sell
99,155
-572,649
-85% -$95.8M 0.06% 425
2025
Q3
$132M Buy
+671,804
New +$110M 0.44% 41
2025
Q2
– Sell
-452,533
Closed -$27M – 1427
2025
Q1
$27M Buy
452,533
+83,616
+23% +$7.73M 0.1% 274
2024
Q4
$48.9M Buy
+368,917
New +$34.6M 0.17% 164
2024
Q2
– Sell
-30,000
Closed -$2.23M – 1391
2024
Q1
$2.23M Buy
+30,000
New +$2.22M 0.01% 834

Other funds holding ALAB

Voloridge Investment Management's ALAB Position: Q2 2026 in Review

Voloridge Investment Management reduced its Astera Labs (ALAB) stake by 57% in Q2 2026, selling an estimated $15.8M and leaving 45,625 shares worth $22M. The position accounts for 0.09% of the portfolio, ranked #284.

Voloridge Investment Management first reported a position in ALAB in Q1 2024 and has held it in 7 quarters since. The position peaked at $132M in Q3 2025. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Voloridge Investment Management held 45,625 shares of Astera Labs worth $22M as of Q2 2026.
  • Voloridge Investment Management sold 59,687 Astera Labs shares in Q2 2026, an estimated $15.8M.
  • Astera Labs made up 0.09% of Voloridge Investment Management's portfolio in Q2 2026, its #284 holding.
  • Voloridge Investment Management first reported a position in Astera Labs in Q1 2024 and has held it in 7 quarters since.
  • Voloridge Investment Management's Astera Labs position peaked at $132M in Q3 2025.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.